Entero Therapeutics raises $3M in private placement; appoints two new directors

GridAI Technologies Corp.

Gross proceeds of $3.0M from sale of pre-funded warrants and common warrants priced at $0.6149 per unit.
$1M paid at closing (Aug 11, 2025); remaining $2M due upon effectiveness of resale registration statement.
Pre-funded warrants exercisable at $0.00001; common warrants at $0.3649, expire 5 years after registration effective.
Geordan Pursglove and Jason Sawyer appointed to Board effective Aug 11, 2025; each receives $2,500/month cash retainer.
Net proceeds for general corporate purposes and working capital.

item 1.01item 3.02item 5.02item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.